SGMT SAGIMET BIOSCIENCES INC Earnings Reports 8-K Filing 2024 - Financial Condition Update Sagimet Biosciences Inc. estimates its cash, cash equivalents, and short-term investments to be approximately $94.9 million as of December 31, 2023.Get access to all SEC 8-K filings of the SAGIMET BIOSCIENCES INC